105 related articles for article (PubMed ID: 11526978)
1. Comparison of N2O- and chlordiazepoxide-induced behaviors in the light/dark exploration test.
Li S; Quock RM
Pharmacol Biochem Behav; 2001 Apr; 68(4):789-96. PubMed ID: 11526978
[TBL] [Abstract][Full Text] [Related]
2. Nitrous oxide anxiolytic effect in mice in the elevated plus maze: mediation by benzodiazepine receptors.
Emmanouil DE; Johnson CH; Quock RM
Psychopharmacology (Berl); 1994 Jun; 115(1-2):167-72. PubMed ID: 7862891
[TBL] [Abstract][Full Text] [Related]
3. Role of cyclic GMP in nitrous-oxide-induced anxiolytic-like behavior in the mouse light-dark exploration test.
Li S; Chung E; Quock RM
Behav Neurosci; 2004 Jun; 118(3):648-52. PubMed ID: 15174944
[TBL] [Abstract][Full Text] [Related]
4. Anxiolytic effects of nitrous oxide in mice in the light-dark and holeboard exploratory tests.
Czech DA; Green DA
Psychopharmacology (Berl); 1992; 109(3):315-20. PubMed ID: 1365632
[TBL] [Abstract][Full Text] [Related]
5. Nitrous oxide induces an anxiolytic-like effect in the conditioned defensive burying paradigm, which can be reversed with a benzodiazepine receptor blocker.
Czech DA; Quock RM
Psychopharmacology (Berl); 1993; 113(2):211-6. PubMed ID: 7855183
[TBL] [Abstract][Full Text] [Related]
6. Involvement of nitric oxide in nitrous oxide anxiolysis in the elevated plus-maze.
Caton PW; Tousman SA; Quock RM
Pharmacol Biochem Behav; 1994 Jul; 48(3):689-92. PubMed ID: 7524106
[TBL] [Abstract][Full Text] [Related]
7. A study of the role of serotonin in the anxiolytic effect of nitrous oxide in rodents.
Emmanouil DE; Papadopoulou-Daifoti Z; Hagihara PT; Quock DG; Quock RM
Pharmacol Biochem Behav; 2006 Jun; 84(2):313-20. PubMed ID: 16828854
[TBL] [Abstract][Full Text] [Related]
8. Benzodiazepine receptor-mediated behavioral effects of nitrous oxide in the rat social interaction test.
Quock RM; Wetzel PJ; Maillefer RH; Hodges BL; Curtis BA; Czech DA
Pharmacol Biochem Behav; 1993 Sep; 46(1):161-5. PubMed ID: 8255907
[TBL] [Abstract][Full Text] [Related]
9. Antidepressant- and anxiolytic-like effects of selective neuronal NOS inhibitor 1-(2-trifluoromethylphenyl)-imidazole in mice.
Volke V; Wegener G; Bourin M; Vasar E
Behav Brain Res; 2003 Mar; 140(1-2):141-7. PubMed ID: 12644287
[TBL] [Abstract][Full Text] [Related]
10. Antagonism of nitrous oxide-induced anxiolytic-like behavior in the mouse light/dark exploration procedure by pharmacologic disruption of endogenous nitric oxide function.
Li S; Ohgami Y; Dai Y; Quock RM
Psychopharmacology (Berl); 2003 Apr; 166(4):366-72. PubMed ID: 12589527
[TBL] [Abstract][Full Text] [Related]
11. Differential effects of nitric oxide synthase inhibitors on anxiety in unstressed and stressed mice.
Gilhotra N; Jain H; Dhingra D
Indian J Exp Biol; 2010 Apr; 48(4):365-72. PubMed ID: 20726334
[TBL] [Abstract][Full Text] [Related]
12. Prior test experience compromises the anxiolytic efficacy of chlordiazepoxide in the mouse light/dark exploration test.
Holmes A; Iles JP; Mayell SJ; Rodgers RJ
Behav Brain Res; 2001 Aug; 122(2):159-67. PubMed ID: 11334646
[TBL] [Abstract][Full Text] [Related]
13. Effects of a nitric oxide donor on behavior and interaction with nitrous oxide in the mouse light/dark exploration test.
Li S; Quock RM
Eur J Pharmacol; 2002 Jun; 447(1):75-8. PubMed ID: 12106805
[TBL] [Abstract][Full Text] [Related]
14. Involvement of cyclic GMP-dependent protein kinase in nitrous oxide-induced anxiolytic-like behavior in the mouse light/dark exploration test.
Li S; Doss JC; Hardee EJ; Quock RM
Brain Res; 2005 Mar; 1038(1):113-7. PubMed ID: 15748880
[TBL] [Abstract][Full Text] [Related]
15. Benzodiazepine receptor mediation of behavioral effects of nitrous oxide in mice.
Quock RM; Emmanouil DE; Vaughn LK; Pruhs RJ
Psychopharmacology (Berl); 1992; 107(2-3):310-4. PubMed ID: 1319602
[TBL] [Abstract][Full Text] [Related]
16. Antagonism by NOS inhibition of the behavioral effects of benzodiazepine and GABAA receptor agonists in the mouse elevated plus-maze.
Elfline GS; Branda EM; Babich M; Quock RM
Neuropsychopharmacology; 2004 Aug; 29(8):1419-25. PubMed ID: 15136793
[TBL] [Abstract][Full Text] [Related]
17. Interactions between LY354740, a group II metabotropic agonist and the GABA(A)-benzodiazepine receptor complex in the rat elevated plus-maze.
Ferris P; Seward E; Dawson GR
J Psychopharmacol; 2001 Jun; 15(2):76-82. PubMed ID: 11448091
[TBL] [Abstract][Full Text] [Related]
18. Anxiolytic-like effects induced by nitric oxide synthase inhibitors microinjected into the medial amygdala of rats.
Forestiero D; Manfrim CM; Guimarães FS; de Oliveira RM
Psychopharmacology (Berl); 2006 Jan; 184(2):166-72. PubMed ID: 16362401
[TBL] [Abstract][Full Text] [Related]
19. Antisense knockdown of neuronal nitric oxide synthase antagonizes nitrous oxide-induced behavior.
Li S; Dai Y; Quock RM
Brain Res; 2003 Apr; 968(1):167-70. PubMed ID: 12644275
[TBL] [Abstract][Full Text] [Related]
20. Beta-CCT, a selective BZ-omega1 receptor antagonist, blocks the anti-anxiety but not the amnesic action of chlordiazepoxide in mice.
Belzung C; Le Guisquet AM; Griebel G
Behav Pharmacol; 2000 Apr; 11(2):125-31. PubMed ID: 10877117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
